We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+7.66%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$455B
AUM Growth
+$26.6B
Cap. Flow
-$26.7B
Cap. Flow %
-5.87%
Top 10 Hldgs %
33.25%
Holding
16,292
New
1,467
Increased
6,223
Reduced
6,687
Closed
1,652

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$645M
2
TMUS icon
T-Mobile US
TMUS
+$640M
3
T icon
AT&T
T
+$517M
4
HUM icon
Humana
HUM
+$481M
5
BSX icon
Boston Scientific
BSX
+$400M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.24B
2
AAPL icon
Apple
AAPL
+$755M
3
META icon
Meta Platforms (Facebook)
META
+$707M
4
CAT icon
Caterpillar
CAT
+$472M
5
AMD icon
Advanced Micro Devices
AMD
+$449M

Sector Composition

Rank Sector Weight
1 Healthcare 3.33%
2 Technology 3.2%
3 Financials 2.22%
4 Industrials 2.17%
5 Consumer Discretionary 2.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CIA icon
14701
Citizens
CIA
$200M
-12,826
Closed -$27.3K
CIA icon
14702
PUT
Citizens
CIA
$200M
-300
Closed -$639
CISO
14703
CALL
CISO Global
CISO
$12.2M
-7
Closed -$255
CISO
14704
PUT
CISO Global
CISO
$12.2M
-2,873
Closed -$110K
CKPT
14705
DELISTED
Checkpoint Therapeutics
CKPT
-64
Closed -$321
CLBT icon
14706
PUT
Cellebrite
CLBT
$2.75B
-18,800
Closed -$82K
CLDI icon
14707
Calidi Biotherapeutics
CLDI
$3.81M
-49
Closed -$954K
CLLS
14708
CALL
Cellectis
CLLS
$312M
-700
Closed -$1.47K
CLLS
14709
Cellectis
CLLS
$312M
-58,207
Closed -$122K
CLLS
14710
PUT
Cellectis
CLLS
$312M
-1,500
Closed -$3.15K
CLNN icon
14711
Clene
CLNN
$53.5M
-173
Closed -$4.49K
CLRB icon
14712
Cellectar Biosciences
CLRB
$20.8M
-622
Closed -$31.9K
CLSM icon
14713
Exchange Listed Funds Trust ETC Cabana Target Leading Sector Moderate ETF
CLSM
$99.6M
-19,081
Closed -$384K
CNET icon
14714
CALL
ZW Data Action Technologies
CNET
$4.95M
-715
Closed -$6.58K
CNET icon
14715
PUT
ZW Data Action Technologies
CNET
$4.95M
-170
Closed -$1.56K
CNTA
14716
DELISTED
Centessa Pharmaceuticals
CNTA
-72,307
Closed -$224K
CNTA
14717
PUT
DELISTED
Centessa Pharmaceuticals
CNTA
-1,000
Closed -$3.1K
CODI icon
14718
Compass Diversified
CODI
$963M
-79,197
Closed -$1.62M
COWG icon
14719
Pacer US Large Cap Cash Cows Growth Leaders ETF
COWG
$2.33B
-20,737
Closed -$412K
CRAI icon
14720
CRA International
CRAI
$1.06B
-27,060
Closed -$3.18M
CRBP icon
14721
CALL
Corbus Pharmaceuticals
CRBP
$197M
-3,123
Closed -$10.4K
CRBP icon
14722
Corbus Pharmaceuticals
CRBP
$197M
-230
Closed -$762
CRBP icon
14723
PUT
Corbus Pharmaceuticals
CRBP
$197M
-160
Closed -$530
CRCT icon
14724
Cricut
CRCT
$1.22B
-6,636
Closed -$64.1K
CRDL
14725
PUT
Cardiol Therapeutics
CRDL
$194M
-1,600
Closed -$816

Similar funds

Ken Griffin's Q1 2023 Portfolio in Review

As of Q1 2023, Ken Griffin held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Ken Griffin withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.

Against the trend, Ken Griffin opened a new position in Keurig Dr Pepper worth $238M.

  • Ken Griffin's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
  • Ken Griffin added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
  • Ken Griffin's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
  • Ken Griffin fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
  • Ken Griffin's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
  • Ken Griffin opened 1,467 new positions and closed 1,652 in Q1 2023.
  • Ken Griffin's portfolio value rose 6.2% quarter-over-quarter to $455B.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.